Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes

Carol O. Tacket, Hugh Mason, Genevieve Losonsky, Mary K. Estes, Myron M. Levine, Charles J. Arntzen

Research output: Contribution to journalArticle

362 Citations (Scopus)

Abstract

A new approach for delivering vaccine antigens is the use of inexpensive, plentiful, plant-based oral vaccines. Norwalk virus capsid protein (NVCP), assembled into virus-like particles, was used as a test antigen, to determine whether immune responses could be generated in volunteers who ingested transgenic potatoes. Twenty-four healthy adult volunteers received 2 or 3 doses of transgenic potato (n = 20) or 3 doses of wild-type potato (n = 4). Each dose consisted of 150 g of raw, peeled, diced potato that contained 215-751 μg of NVCP. Nineteen (95%) of 20 volunteers who ingested transgenic potatoes developed significant increases in the numbers of specific IgA antibody-secreting cells. Four (20%) of 20 volunteers developed specific serum IgG, and 6 (30%) of 20 volunteers developed specific stool IgA. Overall, 19 of 20 volunteers developed an immune response of some kind, although the level of serum antibody increases was modest.

Original languageEnglish (US)
Pages (from-to)302-305
Number of pages4
JournalJournal of Infectious Diseases
Volume182
Issue number1
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Norwalk virus
Solanum tuberosum
Volunteers
Vaccines
Capsid Proteins
Immunoglobulin A
Antigens
Antibody-Producing Cells
Serum
Virion
Healthy Volunteers
Immunoglobulin G
Antibodies

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. / Tacket, Carol O.; Mason, Hugh; Losonsky, Genevieve; Estes, Mary K.; Levine, Myron M.; Arntzen, Charles J.

In: Journal of Infectious Diseases, Vol. 182, No. 1, 2000, p. 302-305.

Research output: Contribution to journalArticle

Tacket, Carol O. ; Mason, Hugh ; Losonsky, Genevieve ; Estes, Mary K. ; Levine, Myron M. ; Arntzen, Charles J. / Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. In: Journal of Infectious Diseases. 2000 ; Vol. 182, No. 1. pp. 302-305.
@article{8624bc0685974b948c8b75e056ced732,
title = "Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes",
abstract = "A new approach for delivering vaccine antigens is the use of inexpensive, plentiful, plant-based oral vaccines. Norwalk virus capsid protein (NVCP), assembled into virus-like particles, was used as a test antigen, to determine whether immune responses could be generated in volunteers who ingested transgenic potatoes. Twenty-four healthy adult volunteers received 2 or 3 doses of transgenic potato (n = 20) or 3 doses of wild-type potato (n = 4). Each dose consisted of 150 g of raw, peeled, diced potato that contained 215-751 μg of NVCP. Nineteen (95{\%}) of 20 volunteers who ingested transgenic potatoes developed significant increases in the numbers of specific IgA antibody-secreting cells. Four (20{\%}) of 20 volunteers developed specific serum IgG, and 6 (30{\%}) of 20 volunteers developed specific stool IgA. Overall, 19 of 20 volunteers developed an immune response of some kind, although the level of serum antibody increases was modest.",
author = "Tacket, {Carol O.} and Hugh Mason and Genevieve Losonsky and Estes, {Mary K.} and Levine, {Myron M.} and Arntzen, {Charles J.}",
year = "2000",
doi = "10.1086/315653",
language = "English (US)",
volume = "182",
pages = "302--305",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes

AU - Tacket, Carol O.

AU - Mason, Hugh

AU - Losonsky, Genevieve

AU - Estes, Mary K.

AU - Levine, Myron M.

AU - Arntzen, Charles J.

PY - 2000

Y1 - 2000

N2 - A new approach for delivering vaccine antigens is the use of inexpensive, plentiful, plant-based oral vaccines. Norwalk virus capsid protein (NVCP), assembled into virus-like particles, was used as a test antigen, to determine whether immune responses could be generated in volunteers who ingested transgenic potatoes. Twenty-four healthy adult volunteers received 2 or 3 doses of transgenic potato (n = 20) or 3 doses of wild-type potato (n = 4). Each dose consisted of 150 g of raw, peeled, diced potato that contained 215-751 μg of NVCP. Nineteen (95%) of 20 volunteers who ingested transgenic potatoes developed significant increases in the numbers of specific IgA antibody-secreting cells. Four (20%) of 20 volunteers developed specific serum IgG, and 6 (30%) of 20 volunteers developed specific stool IgA. Overall, 19 of 20 volunteers developed an immune response of some kind, although the level of serum antibody increases was modest.

AB - A new approach for delivering vaccine antigens is the use of inexpensive, plentiful, plant-based oral vaccines. Norwalk virus capsid protein (NVCP), assembled into virus-like particles, was used as a test antigen, to determine whether immune responses could be generated in volunteers who ingested transgenic potatoes. Twenty-four healthy adult volunteers received 2 or 3 doses of transgenic potato (n = 20) or 3 doses of wild-type potato (n = 4). Each dose consisted of 150 g of raw, peeled, diced potato that contained 215-751 μg of NVCP. Nineteen (95%) of 20 volunteers who ingested transgenic potatoes developed significant increases in the numbers of specific IgA antibody-secreting cells. Four (20%) of 20 volunteers developed specific serum IgG, and 6 (30%) of 20 volunteers developed specific stool IgA. Overall, 19 of 20 volunteers developed an immune response of some kind, although the level of serum antibody increases was modest.

UR - http://www.scopus.com/inward/record.url?scp=0013651896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013651896&partnerID=8YFLogxK

U2 - 10.1086/315653

DO - 10.1086/315653

M3 - Article

C2 - 10882612

AN - SCOPUS:0013651896

VL - 182

SP - 302

EP - 305

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 1

ER -